Provenance
Written by SPS and the College of Sexual and Reproductive Health (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.
Template versions available
Version 3.1 of this PGD template, valid from April 2026, has been published to allow organisations to undertake local governance processes in a timely manner. Version 3.0 has been updated to reflect the revised UKMEC published in December 2025.
Version 2 of this PGD template remains currently valid and will be removed from this page on its expiry (31st March 2026)
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
More reproductive health PGD templates
- Medroxyprogesterone acetate (SC-DMPA) injection for contraception
- Combined hormonal contraceptive transdermal patch
- Combined oral hormonal contraceptive (COC) in reproductive health
- Medroxyprogesterone acetate (DMPA) IM injection for contraception
- Lidocaine injection for subdermal etonogestrel in contraception
- Etonogestrel (e.g. Nexplanon®) implant for contraception
- Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
- Copper Intrauterine Device (Cu-IUD)
- Lidocaine plus prilocaine cream for IUD insertion or removal
- Lidocaine 10mg/ml spray for IUD insertion or removal
- Ulipristal acetate 30mg tablets for emergency contraception
- Progestogen only pill (POP) for contraception
- Levonorgestrel 1500 microgram tablets for emergency contraception
Update history
- Version 3.1 published
- Planned review detail added
- Republished
- Version 3.0 template published and explanatory wording added. Page reviewed.
- Information added regarding name change of FSRH to CoSRH
- Title, URL and summary amended.
- Version 1 removed as expiring end March '23
- Version 2.0 PGD template added
- Revised template added to reflect updated FSRH guidance on use of e-cigarettes/vaping and minor detailed changes
- Published